KLOW Blend
KLOW Blend
Third-Party Tested
Independent lab verified
Batch-Specific CoA
Publicly accessible
YPB.264
Reference number
GHK-Cu 50mg / KPV 10mg / BPC-157 10mg / TB-500 10mg
Lyophilized vial
Four-compound blend: GHK-Cu, KPV, BPC-157, and TB-500. Investigated for gut health and systemic repair research.
Origin
The KLOW Blend combines GHK-Cu (50mg), KPV (10mg), BPC-157 (10mg), and TB-500 (10mg). It adds KPV — the C-terminal tripeptide of alpha-MSH — to the GLOW Blend formulation. KPV contributes anti-inflammatory signaling research properties, particularly in intestinal epithelial models studied by Dalmasso et al.
Research Lineage
The four components span different research traditions: GHK-Cu (collagen/gene expression — Pickart), KPV (alpha-MSH fragment/anti-inflammatory — Brzoska, Dalmasso), BPC-157 (gastric cytoprotection — Sikiric), and TB-500 (thymic peptides/cell migration — Goldstein). The combination targets both repair mechanisms and inflammatory modulation pathways.
Mechanism of Action
The KLOW Blend combines tissue repair peptides (BPC-157, TB-500) with anti-inflammatory (KPV — NF-kB inhibition) and matrix remodeling (GHK-Cu — collagen synthesis and metalloproteinase modulation) compounds. The inclusion of KPV, which has been studied for effects on intestinal epithelial barrier integrity, differentiates this formulation from the GLOW Blend for gut-focused research applications.
Components
GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB-500 (10mg)
Research Use Only. This product is intended for laboratory research purposes only. Not for human or veterinary use. Not for sale to minors.